Physician profile
Mindy Ley
NPI 1043689763
$3,740.64
in general payments reported to CMS, 2019-2025
21 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $409 · 2023: $850 · 2024: $1,274 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,223 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.48 |
| Education | $108.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $783.36 | 2022-2025 | |
| Genzyme Corporation | $490.13 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $414.74 | 2022-2025 | Blu-U, Odomzo, Ilumya |
| Janssen Biotech, INC. | $389.93 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Arcutis Biotherapeutics, INC. | $291.52 | 2023-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $282.96 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $162.16 | 2022-2024 | Dupixent |
| Leo Pharma INC. | $152.40 | 2023-2025 | Adbry |
| Amgen INC. | $128.04 | 2022-2024 | Otezla |
| Dermavant Sciences, INC. | $118.56 | 2023-2024 | Vtama |
| Organon LLC | $78.96 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $74.16 | 2023-2025 | Nemluvio, Aklief |
| Lilly USA, LLC | $73.08 | 2022-2024 | Olumiant |
| Pfizer INC. | $71.09 | 2022-2024 | |
| Ucb, INC. | $62.56 | 2025 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cipher Pharmaceuticals US LLC | $56.85 | 2025 | Spinosad, Natroba |
| Incyte Corporation | $37.89 | 2024-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $24.03 | 2022 | |
| Verrica Pharmaceuticals INC. | $18.66 | 2025 | Ycanth |
| Lnhc, INC | $16.25 | 2025 | Zelsuvmi |
| E.R. Squibb & Sons, L.L.C. | $13.31 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Ley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.